AVIPTADIL SAVES LIVES
  • Share with press and officials
  • How Aviptadil Saves Lives
Aviptadil is a life-saving drug that gives hope to thousands of critically ill COVID-19 patients.
It is available for use right now, but unfortunately, many doctors and hospitals are not aware of it.
​
To get Aviptadil for your patients or loved ones, visit NeuroRX website.
RLF-100, which is a patented formulation of Aviptadil (synthetic human Vasoactive Intestinal Polypeptide, VIP), has been granted:
  • FDA Fast Track Designation
  • FDA emergency use Investigative New Drug authorization
  • Expanded access protocol
​and is awaiting Emergency Use Authorization and full FDA approval

Click articles below for more information:

Miracle recovery by Aviptadil as posted on Facebook

YouTube discussion between Dr. Yogendra and NeuroRX CEO Dr. Jonathan Javitt. Specifically discussing summary results of preliminary data from Phase 2b/3 clinical trial

NeuroRX CEO Dr. Jonathan Javitt discusses Aviptadil begining at 21 minutes 40 seconds

CNBC article on company that owns patent on Aviptadil

Nebraska Governor acknowledges the effectiveness of Aviptadil

Interesting overview of the uses of Vasoactive Intestinal Peptide (VIP) in the body

Yet another Nebraska man's life saved by Aviptadil

Miami doctor recovers from severe COVID-19 after treatment with Aviptadil

In depth article on success of Aviptadil for patient in North Platte, Nebraska (different from article/video below)

European Biotechnology article on Aviptadil

Relief Therapeutics announces successful results from Expanded Access Protocol (EAP)

Video: Houston Methodist Hospital sees encouraging results of Aviptadil study

Israel to conduct Aviptadil study

University of Miami Hospital participating in Aviptadil clinical trial

Article: Nebraska man successfully treated with Aviptadil
Video: Nebraska man successfully treated with Aviptadil

Relief Therapeutics announces enrollment of 150 patients in phase 2b/3 trial of RLF-100™ for Critical COVID-19 patients

Interim results published to ResearchGate

​​Relief Therapeutics announces: Trial is on track for treatment of COVID-19 respiratory failure

Aviptadil is associated with a 9-fold increased probability of survival and recovery from COVID-19 respiratory failure

Rapid recovery seen in patients on ventilators and extracorporeal membrane oxygenation (ECMO)

NeuroRx requests Emergency Use Authorization for RLF-100™ (Aviptadil) in the treatment of patients with critical COVID-19​

FDA grants Investigational New Drug (IND) status for inhaled use of RLF-100 (Aviptadil) to treat patients with COVID-19

Help spread the word
Picture

​Follow us, and share, on Facebook
so the world can learn
​about Aviptadil.

Want to help us spread the word about this life saving drug? Contact us here for details:
contribute2socialmedia@aviptadilsaveslives.com
Disclaimer: this website is not supported or authorized by Relief Therapeutics or NeuroRX.
  • Share with press and officials
  • How Aviptadil Saves Lives
This website is not authorized or supported by Relief Therapeutics AG or NeuroRX.